Use this document to submit brand price change for drugs listed on the Yukon Drug Formulary. View the Yukon Drug Formulary.
Documents
Displaying 9751 - 9753 of 9753
81-106 National Instrument, Investment Fund Continuous Disclosure, Securities Act, Amendment Effective March 3, 2025.